Cargando…

Medication Adherence in Vietnamese Patients with Cardiovascular and Endocrine–Metabolic Diseases

(1) Background: COVID-19 has significantly affected the quality of life and the medication adherence of patients with chronic diseases. Attitudes towards the disease and preventive measures are the things that need to be considered for patient adherence to medication during the COVID-19 pandemic. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Ly, Hung Huynh Vinh, Le, Ngoc Nguyen Minh, Ha, Mai Thi Thao, Diep, Han Gia, Lam, Anh Nhut, Nguyen, Thao Thi Thanh, Le, Duyen Thi Nhan, Nguyen, Trang Thi Nhu, Le, Tu Thi Cam, Taxis, Katja, Pham, Suol Thanh, Dang, Khanh Duy, Nguyen, Thang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498879/
https://www.ncbi.nlm.nih.gov/pubmed/36141346
http://dx.doi.org/10.3390/healthcare10091734
_version_ 1784794869975220224
author Ly, Hung Huynh Vinh
Le, Ngoc Nguyen Minh
Ha, Mai Thi Thao
Diep, Han Gia
Lam, Anh Nhut
Nguyen, Thao Thi Thanh
Le, Duyen Thi Nhan
Nguyen, Trang Thi Nhu
Le, Tu Thi Cam
Taxis, Katja
Pham, Suol Thanh
Dang, Khanh Duy
Nguyen, Thang
author_facet Ly, Hung Huynh Vinh
Le, Ngoc Nguyen Minh
Ha, Mai Thi Thao
Diep, Han Gia
Lam, Anh Nhut
Nguyen, Thao Thi Thanh
Le, Duyen Thi Nhan
Nguyen, Trang Thi Nhu
Le, Tu Thi Cam
Taxis, Katja
Pham, Suol Thanh
Dang, Khanh Duy
Nguyen, Thang
author_sort Ly, Hung Huynh Vinh
collection PubMed
description (1) Background: COVID-19 has significantly affected the quality of life and the medication adherence of patients with chronic diseases. Attitudes towards the disease and preventive measures are the things that need to be considered for patient adherence to medication during the COVID-19 pandemic. We aimed to evaluate the rate and compare the medication adherence and the impact of the COVID-19 pandemic on medication adherence in Vietnamese patients with cardiovascular and endocrine–metabolic diseases. (2) Methods: A cross-sectional study was conducted on outpatients having chronic diseases such as cardiovascular or/and endocrine–metabolic diseases in some southern provinces in Vietnam. In each group of patients, medication adherence was measured and assessed with the General Medication Adherence Scale (GMAS), adjusted and validated in Vietnam. In addition, the study also investigated attitudes and practices to prevent COVID-19. (3) Results: Out of 1444 patients in our study, the level of adherence was recorded in 867 cases, accounting for 61.1%. The group of patients with only cardiovascular disease and patients with only endocrine–metabolic disease had relatively similar compliance rates of 62 and 61.1%, respectively. The leading cause of non-adherence to treatment in all three groups of patients in the study, as assessed by the GMAS, was non-adherence due to financial constraints. Our study showed that 71.6% of patients felt anxious when going to the hospital for a medical examination. However, only 53.7% identified the COVID-19 pandemic as obstructing treatment follow-up visits. The research results showed that the COVID-19 epidemic influences the patient’s psychology with regard to re-examination and treatment adherence, with p coefficients of 0.003 and <0.001, respectively. (4) Conclusion: Medication adherence rates in two disease groups are close, and financial constraint is the fundamental reason for medication non-adherence. Regulatory agencies must take care of people’s welfare to improve adherence in the epidemic context.
format Online
Article
Text
id pubmed-9498879
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94988792022-09-23 Medication Adherence in Vietnamese Patients with Cardiovascular and Endocrine–Metabolic Diseases Ly, Hung Huynh Vinh Le, Ngoc Nguyen Minh Ha, Mai Thi Thao Diep, Han Gia Lam, Anh Nhut Nguyen, Thao Thi Thanh Le, Duyen Thi Nhan Nguyen, Trang Thi Nhu Le, Tu Thi Cam Taxis, Katja Pham, Suol Thanh Dang, Khanh Duy Nguyen, Thang Healthcare (Basel) Article (1) Background: COVID-19 has significantly affected the quality of life and the medication adherence of patients with chronic diseases. Attitudes towards the disease and preventive measures are the things that need to be considered for patient adherence to medication during the COVID-19 pandemic. We aimed to evaluate the rate and compare the medication adherence and the impact of the COVID-19 pandemic on medication adherence in Vietnamese patients with cardiovascular and endocrine–metabolic diseases. (2) Methods: A cross-sectional study was conducted on outpatients having chronic diseases such as cardiovascular or/and endocrine–metabolic diseases in some southern provinces in Vietnam. In each group of patients, medication adherence was measured and assessed with the General Medication Adherence Scale (GMAS), adjusted and validated in Vietnam. In addition, the study also investigated attitudes and practices to prevent COVID-19. (3) Results: Out of 1444 patients in our study, the level of adherence was recorded in 867 cases, accounting for 61.1%. The group of patients with only cardiovascular disease and patients with only endocrine–metabolic disease had relatively similar compliance rates of 62 and 61.1%, respectively. The leading cause of non-adherence to treatment in all three groups of patients in the study, as assessed by the GMAS, was non-adherence due to financial constraints. Our study showed that 71.6% of patients felt anxious when going to the hospital for a medical examination. However, only 53.7% identified the COVID-19 pandemic as obstructing treatment follow-up visits. The research results showed that the COVID-19 epidemic influences the patient’s psychology with regard to re-examination and treatment adherence, with p coefficients of 0.003 and <0.001, respectively. (4) Conclusion: Medication adherence rates in two disease groups are close, and financial constraint is the fundamental reason for medication non-adherence. Regulatory agencies must take care of people’s welfare to improve adherence in the epidemic context. MDPI 2022-09-09 /pmc/articles/PMC9498879/ /pubmed/36141346 http://dx.doi.org/10.3390/healthcare10091734 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ly, Hung Huynh Vinh
Le, Ngoc Nguyen Minh
Ha, Mai Thi Thao
Diep, Han Gia
Lam, Anh Nhut
Nguyen, Thao Thi Thanh
Le, Duyen Thi Nhan
Nguyen, Trang Thi Nhu
Le, Tu Thi Cam
Taxis, Katja
Pham, Suol Thanh
Dang, Khanh Duy
Nguyen, Thang
Medication Adherence in Vietnamese Patients with Cardiovascular and Endocrine–Metabolic Diseases
title Medication Adherence in Vietnamese Patients with Cardiovascular and Endocrine–Metabolic Diseases
title_full Medication Adherence in Vietnamese Patients with Cardiovascular and Endocrine–Metabolic Diseases
title_fullStr Medication Adherence in Vietnamese Patients with Cardiovascular and Endocrine–Metabolic Diseases
title_full_unstemmed Medication Adherence in Vietnamese Patients with Cardiovascular and Endocrine–Metabolic Diseases
title_short Medication Adherence in Vietnamese Patients with Cardiovascular and Endocrine–Metabolic Diseases
title_sort medication adherence in vietnamese patients with cardiovascular and endocrine–metabolic diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498879/
https://www.ncbi.nlm.nih.gov/pubmed/36141346
http://dx.doi.org/10.3390/healthcare10091734
work_keys_str_mv AT lyhunghuynhvinh medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT lengocnguyenminh medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT hamaithithao medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT diephangia medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT lamanhnhut medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT nguyenthaothithanh medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT leduyenthinhan medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT nguyentrangthinhu medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT letuthicam medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT taxiskatja medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT phamsuolthanh medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT dangkhanhduy medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases
AT nguyenthang medicationadherenceinvietnamesepatientswithcardiovascularandendocrinemetabolicdiseases